Taking a Collaborative Approach to Hemophilia Management

Tim Boonstra, RPh, Pharmacy Manager at Fairview Center for Bleeding and Clotting Disorders, discusses the collaborative approach taken at his clinic in the management and treatment of patients with hemophilia.


All our patients are required by our government grant to come in on an annual basis for what they call a comprehensive clinic appointment. And at that appointment, they meet with all the various disciplines: physicians, nurses, social work, physical therapy, and pharmacy. We have a huddle room where we go to and share what we learn when each of us visit that patient during that appointment. And that appointment is a long one, it’s about a 3-hour long appointment. But it provides valuable information to what’s going on with that patient that day.

Related Articles

Aptevo Therapeutics announced the launch of its new vial size for its coagulation factor IX recombinant (Ixinity) treatment for hemophilia B in the US market.
A recent study showed that adherence to prophylaxis for severe hemophilia A can improve a patient’s physical performance.
Patients with hemophilia A across all age groups reported stabilization or improvement of quality of life and high treatment satisfaction.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.